After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of PTC Therapeutics Inc is $3.56B. A total of 0.9 million shares were traded on the day, compared to an average of 741.66K shares.
In the most recent transaction, Utter Christine Marie sold 1,662 shares of PTCT for 44.50 per share on Jan 08 ’25. After the transaction, the SVP, CHIEF ACCOUNTING OFFICER now owns 64,321 company shares. In a previous transaction on Jan 07 ’25, Utter Christine Marie sold 1,291 shares at 45.34 per share. PTCT shares that SVP, CHIEF ACCOUNTING OFFICER owns now total 65,983.
Among the insiders who sold shares, Pauwels Eric disposed of 2,136 shares on Jan 08 ’25 at a per-share price of $44.50. This resulted in the CHIEF EXECUTIVE OFFICER holding 86,805 shares of PTCT after the transaction. In another insider transaction, Pauwels Eric sold 1,599 shares at $45.34 per share on Jan 07 ’25. Company shares held by the CHIEF EXECUTIVE OFFICER now total 88,941.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, PTCT has a high of $54.16 and a low of $23.58.
As of this writing, PTCT has an earnings estimate of -$0.73 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.39 per share and a lower estimate of -$0.94.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PTCT’s latest balance sheet shows that the firm has $773.38M in Cash & Short Term Investments as of fiscal 2021. There were $1.27B in debt and $509.35M in liabilities at the time. Its Book Value Per Share was -$13.70, while its Total Shareholder’s Equity was $1.44M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTCT is Buy with a score of 3.80.
